Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study.

Wray C, Scovotti JC, Tobis J, Niemann CU, Planinsic R, Walia A, Findlay J, Wagener G, Cywinski JB, Markovic D, Hughes C, Humar A, Olmos A, Sierra R, Busuttil R, Steadman RH.

Am J Transplant. 2013 Jan;13(1):184-91. doi: 10.1111/j.1600-6143.2012.04293.x. Epub 2012 Nov 5.

2.

Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.

Satapathy SK, Vanatta JM, Helmick RA, Flowers A, Kedia SK, Jiang Y, Ali B, Eason J, Nair SP, Ibebuogu UN.

Transplantation. 2017 Apr;101(4):793-803. doi: 10.1097/TP.0000000000001647.

PMID:
28099403
3.

Nonobstructive coronary artery disease and risk of myocardial infarction.

Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS.

JAMA. 2014 Nov 5;312(17):1754-63. doi: 10.1001/jama.2014.14681.

4.

Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease.

Patel S, Kiefer TL, Ahmed A, Ali ZA, Tremmel JA, Lee DP, Yeung AC, Fearon WF.

Am J Cardiol. 2011 Dec 1;108(11):1552-5. doi: 10.1016/j.amjcard.2011.07.013. Epub 2011 Sep 3.

PMID:
21890080
5.

Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation.

Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, Ports TA, Gregoratos G, Yeghiazarians Y, Boyle AJ.

Liver Transpl. 2010 Nov;16(11):1242-8. doi: 10.1002/lt.22152.

6.

The prevalence of coronary artery disease in liver transplant candidates over age 50.

Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, Vogt DP, Mayes JT, Westveer MK, Easley KA.

Transplantation. 1995 Mar 27;59(6):859-64.

PMID:
7701580
7.

Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease.

Rossini R, Capodanno D, Lettieri C, Musumeci G, Limbruno U, Molfese M, Spatari V, Calabria P, Romano M, Tarantini G, Gavazzi A, Angiolillo DJ.

Am J Cardiol. 2013 Jul 15;112(2):150-5. doi: 10.1016/j.amjcard.2013.03.006. Epub 2013 Apr 18.

PMID:
23602693
8.

The role of coronary calcium score in the risk assessment of liver transplant candidates.

Kemmer N, Case J, Chandna S, Neff GW.

Transplant Proc. 2014 Jan-Feb;46(1):230-3. doi: 10.1016/j.transproceed.2013.09.035.

PMID:
24507057
9.

Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation.

Zanotti G, Hartwig MG, Castleberry AW, Martin JT, Shaw LK, Williams JB, Lin SS, Davis RD.

Transplantation. 2014 May 27;97(10):1079-85. doi: 10.1097/01.TP.0000438619.96933.02. Erratum in: Transplantation. 2015 Feb;99(2):e15.

10.

Cardiac testing for coronary artery disease in potential kidney transplant recipients.

Wang LW, Fahim MA, Hayen A, Mitchell RL, Baines L, Lord S, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008691. doi: 10.1002/14651858.CD008691.pub2. Review.

PMID:
22161434
11.

Liver transplantation in recipients over 65 yr old: a single center experience.

Audet M, Piardi T, Panaro F, Cag M, Ghislotti E, Habibeh H, Giulini SM, Jaeck D, Wolf Ph.

Clin Transplant. 2010 Jan-Feb;24(1):84-90. doi: 10.1111/j.1399-0012.2009.00972.x. Epub 2009 Feb 17.

PMID:
19228173
12.

Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?

Radovancevic B, Golino A, Vrtovec B, Thomas CD, Radovancevic R, Odegaard P, van Rossem CC, Gaemers SJ, Vaughn WK, Smart FW, Frazier OH.

J Heart Lung Transplant. 2005 Jun;24(6):703-7.

PMID:
15949730
13.

Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an InteRnational Multicenter Registry.

Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury R, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Karlsberg RP, Kim YJ, Leipsic J, Labounty TM, Lin FY, Maffei E, Raff G, Villines TC, Shaw LJ, Berman DS, Min JK.

Diabetes Care. 2012 Aug;35(8):1787-94. doi: 10.2337/dc11-2403. Epub 2012 Jun 14.

14.

Silent coronary artery disease in Japanese patients undergoing carotid artery stenting.

Enomoto Y, Yoshimura S, Yamada K, Kawasaki M, Nishigaki K, Minatoguchi S, Iwama T.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1163-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.013. Epub 2013 Jan 22.

PMID:
23352686
15.

Influence of coronary artery disease assessment and treatment in the incidence of cardiac events in renal transplant recipients.

De Lima JJ, Gowdak LH, de Paula FJ, Arantes RL, Ianhez LE, Ramires JA, Krieger EM.

Clin Transplant. 2010 Jul-Aug;24(4):474-80. doi: 10.1111/j.1399-0012.2009.01150.x.

PMID:
19919611
16.

Invasive coronary procedure use and outcomes among veterans with posttraumatic stress disorder: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Bradley SM, Stanislawski MA, Bekelman DB, Monteith LL, Cohen BE, Schilling JH, Hunt SC, Milek D, Maddox TM, Ho PM, Shore S, Varosy PD, Matthieu MM, Rumsfeld JS.

Am Heart J. 2014 Sep;168(3):381-390.e6. doi: 10.1016/j.ahj.2014.05.015. Epub 2014 Jun 9.

PMID:
25173551
17.

Pretransplant coronary artery disease associated with worse clinical outcomes in pancreas transplantation.

Mangus RS, Powelson J, Kinsella SB, Farar DT, Creal CA, Fridell JA.

Clin Transplant. 2013 Jul-Aug;27(4):E442-7. doi: 10.1111/ctr.12185.

PMID:
23923972
18.

Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database.

Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW.

J Heart Lung Transplant. 1998 Aug;17(8):744-53.

PMID:
9730422
19.

Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease.

Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV.

Eur Urol. 2014 Jan;65(1):177-85. doi: 10.1016/j.eururo.2012.08.070. Epub 2012 Sep 7.

PMID:
22981136
20.

Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.

Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D.

Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115.

Supplemental Content

Support Center